Interesting timing of this publication and this NY Times article...https://www.nytimes.com/2021/02/16/health/covid-children-inflammatory-syndrome.html?action=click&module=Top%20Stories&pgtype=Homepage
I previously linked to this study (https://pediatrics.aappublications.org/content/147/2/e2020024554) - children were evaluated with MIS-C and it found the symptoms were similar to Kawasaki-disease. The common treatment was intravenous immunoglobulin and steroids, as well as Azithromycin, Anakinra, infliximab, and hydroxychloroquine. No patients were given REM-L as I understand this was prior to the expanded access use in the States was granted.
MSB needs to come out and say what there path forward is for this. There are 30 kids in US with MIS-C and 30 kids in Sweden, plus many more across the world. There are a number of treatments, but what is MSB doing to "get to the front of the cue" given it has a published journal saying its treatment works.
2 kids treated over 6 + months - if the treatment is so successful why are we sitting around?
- Forums
- ASX - By Stock
- MSB
- Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-109
-
- There are more pages in this discussion • 315 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.09 |
Change
0.060(5.83%) |
Mkt cap ! $1.244B |
Open | High | Low | Value | Volume |
$1.04 | $1.10 | $1.03 | $4.925M | 4.571M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7260 | $1.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.10 | 67541 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7260 | 1.090 |
1 | 25000 | 1.085 |
5 | 82706 | 1.080 |
3 | 70397 | 1.075 |
5 | 96320 | 1.070 |
Price($) | Vol. | No. |
---|---|---|
1.095 | 67541 | 7 |
1.100 | 660901 | 37 |
1.105 | 27523 | 3 |
1.110 | 173120 | 11 |
1.115 | 55278 | 5 |
Last trade - 16.10pm 26/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |